Zoetis | ZTS - Net Income

Stock Price
116.73
Daily Change
-1.14 -0.97%
Monthly
0.34%
Yearly
-24.90%
Q2 Forecast
114.37

Zoetis reported $603M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
Align Technology USD 135.76M 79.01M Dec/2025
Bayer EUR -3.76B 2.79B Dec/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Charles River Laboratories USD -276.56M 330.98M Dec/2025
Coherus Biosciences USD -37.64M 2.11M Dec/2025
Dentsply International USD -146M 281M Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Henry Schein USD 101M 0 Dec/2025
Idexx Laboratories USD 248.19M 26.42M Dec/2025
Illumina USD 334M 184M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
J&J USD 5.24B 119M Mar/2026
Laboratory Of America USD 164.7M 96.4M Dec/2025
Merck USD 2.96B 2.82B Dec/2025
Neogen USD -17M 1.08M Dec/2025
Pacira USD 1.64M 3.8M Dec/2025
Perrigo USD -1.42B 1.43B Dec/2025
Pfizer USD -1.65B 5.19B Dec/2025
Phibro Animal Health USD 27.46M 932K Dec/2025
Quest Diagnostics USD 251M 6M Mar/2026
Sanofi EUR 1.61B 2.42B Mar/2026
Sanofi EUR -801M 3.6B Dec/2025
Zoetis USD 603M 118M Dec/2025